Dr. Michael Edward Godzala Iii is a Buffalo, New York based psychiatrist with 17 years of experience in Psychiatry. He completed his graduation from State University Of New York At Buffalo School Of Medicine in 2008. He accepts the Medicare-approved amount. Patients will not be billed for any more than the Medicare deductible and coinsurance. Active license number of Dr. Michael Edward Godzala Iii is 264145 for Psychiatry in New York. His current practice location is 206 S Elmwood Ave, Buffalo. Patients can reach him at 716-847-2441. Dr. Michael Edward Godzala Iii is MD in Psychiatry and his NPI number (Unique professional ID assigned by NPPES) is 1215170030.
Dr. Michael Edward Godzala Iii specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.
Complete Profile:
Dr. Michael Edward Godzala Iii speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
| Name: | Dr. Michael Edward Godzala Iii |
| Specialization: | Psychiatry |
| Gender: | Male |
| Credentials: | MD |
| Experience: | 17+ years |
| Medical School Attended: | State University Of New York At Buffalo School Of Medicine |
| Graduation Year: | 2008 |
| Accepts Medicare Assignment: | Yes |
| Practice Address: | 206 S Elmwood Ave, Buffalo,
New York, 14201-2398 |
| Phone: | 716-847-2441 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
| PAC ID: | 3072778612 |
| Enrollment ID: | I20120703000516 |
| NPI Number: | 1215170030 |
| NPI Enumeration Date: | 08 Apr, 2009 |
| NPI Last Update On: | 28 Oct, 2025 |
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Michael Edward Godzala Iii are as mentioned below.
| License Number | Specialization | State | Status | |
| 264145 | Psychiatry | New York | Primary | |
Group Practice:
Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name
with which Dr. Michael Edward Godzala Iii is associated with along with the number of members in that group.
| Organization Name (Group PAC ID) | Members |
| Ehs, Inc (7618946310) | 35 |
| Horizon Health Services Inc (5698689925) | 53 |
Other Medical Identifiers:
Other legacy medical identifiers associated with Dr. Michael Edward Godzala Iii such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
| Identifier | Type | State | Issuer |
| 03725371 | Medicaid | New York | |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | Dr. Michael Edward Godzala Iii
206 S Elmwood Ave,
Buffalo, New York |
| Zip: | 14201-2398 |
| Phone Number: | 716-847-2441 |
Patients can reach Dr. Michael Edward Godzala Iii at
206 S Elmwood Ave, Buffalo, New York or can
call to book an appointment on 716-847-2441.
Comments/ Reviews:
Read all the reviews posted for Dr. Michael Edward Godzala Iii below. You may also share your own experience with Dr. Michael Edward Godzala Iii. Your feedback can help others make better decisions.
**
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.